HDAC6 and plasma cell myeloma: We assume that HDAC6-dependent α-tubulin acetylation contributes to the decreased cell motility and invasive migration of myeloma cells; thus, this action of the As2O3-induced α-tubulin acetylation could be one of the reasons for As2O3 in myeloma treatment.